S
Simcere Pharmaceutical Group
Sustainability Report and Carbon Intensity Rankings
Is Simcere Pharmaceutical Group doing their part?
Their DitchCarbon score is 42
Simcere Pharmaceutical Group has a DitchCarbon Score of 42 out of 100, indicating moderate performance in sustainability practices. This score suggests that the company’s carbon intensity is relatively high, implying there is significant room for improvement in reducing emissions. To enhance its sustainability efforts, Simcere Pharmaceutical Group needs to focus on lowering its carbon intensity through more effective environmental strategies.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Simcere Pharmaceutical Group is part of the pharmaceutical industry, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Simcere Pharmaceutical Group, located in China, operates in a region with a specific carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon intensity, affecting its environmental impact.
Unlock 30+ emissions data points on Simcere Pharmaceutical Group
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Simcere Pharmaceutical Group
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
0.71%
...this company is doing 0.71% better in emissions than the industry average.
Simcere Pharmaceutical Group, founded in 1995 in Nanjing, Jiangsu, operates within the industrial manufacturing sector of the pharmaceutical industry. As a modern integrated enterprise, it specializes in research, industry, and trade, focusing on the development of innovative drugs. With a strong commitment to health and unprecedented creation, Simcere offers a diverse portfolio of over 50 products, including several that are first to market globally and domestically, and maintains a robust international presence through strategic partnerships and investments.
emission intelligence's platform recommendations for Simcere Pharmaceutical Group
Simcere Pharmaceutical Group should set tangible reduction goals for all forms of purchased energy, including electricity, heat, steam, and cooling, to bolster their transition to renewable sources and enhance their monitoring and reporting systems for continuous improvement opportunities, potentially reducing emissions by 30%.
Bad news, Simcere Pharmaceutical still hasn't committed to SBTi goals.
Simcere Pharmaceutical Group has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.